# RXO, Inc.: overview

RXO · NYSE · CIK 1929561 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/rxo.md) · [Financials](/companies/rxo/financials.md) · [Filings](/companies/rxo/filings.md) · [Insiders](/companies/rxo/insiders.md)

Latest reported revenue: [$1.87bn](/filings/0001929561-26-000049.md) for Q3 FY2026, three months to 2026-09-30, from the 10-Q filed Oct 29, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001929561-26-000049).

## Last eight quarters

| Line item | Unit | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,667 d](/filings/0001929561-26-000013.md) | [1,433](/filings/0001929561-26-000026.md) | [1,419](/filings/0001929561-26-000036.md) | [1,421](/filings/0001929561-26-000049.md) | [1,469 d](/filings/0001929561-26-000013.md) | [1,425](/filings/0001929561-26-000026.md) | [1,774](/filings/0001929561-26-000036.md) | [1,871](/filings/0001929561-26-000049.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [(1.4%) d](/filings/0001929561-26-000013.md) | [(2.1%)](/filings/0001929561-26-000026.md) | [0.0%](/filings/0001929561-26-000036.md) | [(0.5%)](/filings/0001929561-26-000049.md) | [(2.9%) d](/filings/0001929561-26-000013.md) | [(2.0%)](/filings/0001929561-26-000026.md) | [0.1%](/filings/0001929561-26-000036.md) | [0.9%](/filings/0001929561-26-000049.md) |
| Net margin | % | [(1.5%) d](/filings/0001929561-26-000013.md) | [(2.2%)](/filings/0001929561-26-000026.md) | [(0.6%)](/filings/0001929561-26-000036.md) | [(1.0%)](/filings/0001929561-26-000049.md) | [(3.1%) d](/filings/0001929561-26-000013.md) | [(2.5%)](/filings/0001929561-26-000026.md) | [(0.5%)](/filings/0001929561-26-000036.md) | [0.2%](/filings/0001929561-26-000049.md) |
| Diluted EPS | $ per share | not reported | [(0.18)](/filings/0001929561-26-000026.md) | [(0.05)](/filings/0001929561-26-000036.md) | [(0.08)](/filings/0001929561-26-000049.md) | not reported | [(0.21)](/filings/0001929561-26-000026.md) | [(0.05)](/filings/0001929561-26-000036.md) | [0.02](/filings/0001929561-26-000049.md) |
| Free cash flow | $m | [(19.0) d](/filings/0001929561-26-000013.md) | [(17.0)](/filings/0001929561-26-000026.md) | [9.0 d](/filings/0001929561-26-000036.md) | [9.0 d](/filings/0001929561-26-000049.md) | [(9.0) d](/filings/0001929561-26-000013.md) | [(24.0)](/filings/0001929561-26-000026.md) | [(52.0) d](/filings/0001929561-26-000036.md) | [12.0 d](/filings/0001929561-26-000049.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 12-month figure less the 9-month figure; 6-month figure less the 3-month figure; 9-month figure less the 6-month figure.

## Last five fiscal years

| Line item | Unit | FY (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [4,689](/filings/0001929561-24-000032.md) | [4,796](/filings/0001929561-25-000044.md) | [3,927](/filings/0001929561-26-000013.md) | [4,550](/filings/0001929561-26-000013.md) | [5,742](/filings/0001929561-26-000013.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [4.1%](/filings/0001929561-24-000032.md) | [2.6%](/filings/0001929561-25-000044.md) | [1.0%](/filings/0001929561-26-000013.md) | [(1.2%)](/filings/0001929561-26-000013.md) | [(1.4%)](/filings/0001929561-26-000013.md) |
| Net margin | % | [3.2%](/filings/0001929561-24-000032.md) | [1.9%](/filings/0001929561-25-000044.md) | [0.1%](/filings/0001929561-26-000013.md) | [(6.4%)](/filings/0001929561-26-000013.md) | [(1.7%)](/filings/0001929561-26-000013.md) |
| Diluted EPS | $ per share | [1.30](/filings/0001929561-24-000032.md) | [0.79](/filings/0001929561-25-000044.md) | [0.03](/filings/0001929561-26-000013.md) | [(2.17)](/filings/0001929561-26-000013.md) | [(0.59)](/filings/0001929561-26-000013.md) |
| Free cash flow | $m | [116](/filings/0001929561-24-000032.md) | [253](/filings/0001929561-25-000044.md) | [25.0](/filings/0001929561-26-000013.md) | [(57.0)](/filings/0001929561-26-000013.md) | [(8.0)](/filings/0001929561-26-000013.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/rxo/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [Orbis Allan Gray Ltd](/funds/1663865.md) | 2026-06-30 | $1.00bn | 36,397,974 |  | Unchanged |
| [MFN Partners Management, LP](/funds/1732811.md) | 2026-06-30 | $775.6m | 28,109,942 |  | Unchanged |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $693.5m | 25,135,757 |  | Added +969,878 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $256.3m | 9,290,827 |  | Added +256,028 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $205.0m | 7,430,859 |  | Added +60,375 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $183.7m | 6,658,205 |  | Added +89,865 |
| [Hood River Capital Management LLC](/funds/1578177.md) | 2026-06-30 | $178.7m | 6,478,546 |  | Added +2,026,330 |
| [Finepoint Capital LP](/funds/1608126.md) | 2026-06-30 | $147.8m | 5,355,445 |  | Reduced −4,718,173 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $117.8m | 4,269,292 |  | Added +282,209 |
| [Douglas Lane & Associates, LLC](/funds/1672594.md) | 2026-06-30 | $92.3m | 3,346,342 |  | Reduced −160,184 |

## Recent filings

[All 310 filings](/companies/rxo/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-29 | 16:17 ET | [10-Q](/filings/0001929561-26-000049.md) | Quarterly report, period 2026-09-30 | 0001929561-26-000049 |
| 2026-10-29 | 07:33 ET | [8-K](/filings/0001929561-26-000046.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001929561-26-000046 |
| 2026-10-05 | 18:42 ET | [SCHEDULE 13D](/filings/0001193125-26-414547.md) | Ownership report, active investor | 0001193125-26-414547 |
| 2026-10-05 | 08:17 ET | [8-K](/filings/0001140361-26-038548.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-26-038548 |
| 2026-09-09 | 07:31 ET | [8-K](/filings/0001929561-26-000041.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001929561-26-000041 |
| 2026-08-06 | 16:27 ET | [10-Q](/filings/0001929561-26-000036.md) | Quarterly report, period 2026-06-30 | 0001929561-26-000036 |
| 2026-08-06 | 06:31 ET | [8-K](/filings/0001929561-26-000033.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001929561-26-000033 |
| 2026-05-13 | 16:16 ET | [8-K](/filings/0001929561-26-000029.md) | 5.07 Shareholder vote results | 0001929561-26-000029 |
| 2026-05-07 | 16:19 ET | [10-Q](/filings/0001929561-26-000026.md) | Quarterly report, period 2026-03-31 | 0001929561-26-000026 |
| 2026-05-07 | 06:31 ET | [8-K](/filings/0001929561-26-000023.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001929561-26-000023 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001929561-26-000013.md), filed Feb 9, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, has been scored from the reported figures. [See the target](/leagues/2026q3/targets/4c31699c-92f9-43e3-95de-254f307952ac)

## About the filer

- CIK: 1929561
- Tickers: RXO
- Exchange: NYSE
- SIC code: 4700 Transportation Services
- State of incorporation: DE
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 30, 2026, 16:12 ET. No prices; not investment advice.